As August 2026 unfolds, the Asian markets are navigating a complex landscape marked by global economic uncertainties and fluctuating investor sentiment. Amid these challenges, growth companies with high insider ownership stand out as potentially resilient players, often benefiting from strong internal commitment and alignment of interests.
| Name | Insider Ownership | Earnings Growth |
| Shanghai Biren Technology (SEHK:6082) | 10.4% | 118.4% |
| Seojin SystemLtd (KOSDAQ:A178320) | 18% | 110.8% |
| SEERS (KOSDAQ:A458870) | 33.7% | 39.7% |
| Ningbo Sanxing Medical ElectricLtd (SHSE:601567) | 24.9% | 45.6% |
| L&C BIOLTD (KOSDAQ:A290650) | 24% | 148.5% |
| Jiangxi Fushine Pharmaceutical (SZSE:300497) | 21.1% | 50.8% |
| HUMAN MADE (TSE:456A) | 23.9% | 29.2% |
| Great Microwave Technology (SHSE:688270) | 29.5% | 85.5% |
| Fulin Precision (SZSE:300432) | 11.2% | 60.7% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 41% |
Let's uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: China XLX Fertiliser Ltd. is an investment holding company focused on the development, manufacture, and sale of urea in Mainland China and internationally, with a market cap of HK$14.96 billion.
Operations: The company generates revenue from several segments, including Fertilizer - Urea (CN¥9.71 billion), Fertilizer - Compound Fertilizer (CN¥8.47 billion), Chemicals - Methanol (CN¥6.84 billion), Chemicals - Liquid Ammonia (CN¥2.61 billion), Chemicals - DMF (CN¥1.12 billion), Chemicals - Melamine (CN¥881.61 million), and Chemicals - Polyoxymethylene (CN¥405.76 million).
Insider Ownership: 19.6%
Revenue Growth Forecast: 13.3% p.a.
China XLX Fertiliser is experiencing robust growth, with earnings expected to rise by 25.45% annually, outpacing the Hong Kong market. The company anticipates a net profit of RMB 1.15 billion to RMB 1.23 billion for H1 2026, driven by operational efficiencies and favorable market conditions. Despite lower profit margins compared to last year, insider buying suggests confidence in its future prospects. However, high debt levels and unsustainable dividend coverage warrant cautious consideration.
Simply Wall St Growth Rating: ★★★★★☆
Overview: EACON Group Co., Ltd specializes in developing and providing autonomous haulage solutions for the mining industry, with a market cap of HK$13.12 billion.
Operations: The company generates revenue of CN¥1.44 billion from its autonomous driving solutions for mining transportation and production.
Insider Ownership: 28.6%
Revenue Growth Forecast: 27.8% p.a.
EACON Group's revenue is forecast to grow at 27.8% annually, surpassing the Hong Kong market average. Despite a net loss of CNY 517.82 million in 2025, its earnings are projected to increase by nearly 100% per year, becoming profitable within three years. The recent HKD 2.30 billion IPO supports capital needs but highlights less than one year of cash runway, requiring careful financial management amidst high insider ownership and no recent insider trading activity.
Simply Wall St Growth Rating: ★★★★★☆
Overview: IntelliEPI Inc. (Cayman) produces and sells epitaxy wafers of compound semiconductors for applications in wireless communications, data transmission, and national defense across various international markets, with a market cap of NT$23.51 billion.
Operations: The company generates NT$1.14 billion in revenue through its semiconductor segment, focusing on epitaxy wafers for diverse applications.
Insider Ownership: 12.5%
Revenue Growth Forecast: 27.3% p.a.
IntelliEPI (Cayman) is experiencing robust growth, with revenue projected to increase by 27.3% annually, outpacing the Taiwan market average. The company recently became profitable, and earnings are expected to grow significantly at 49.3% per year, exceeding the market's rate of 26%. Despite this promising outlook, the stock has been highly volatile over the past three months. There is no recent insider trading activity reported.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com